Moderna Stock Surges as Hantavirus Vaccine Research Lights Up After Cruise Ship Outbreak

Moderna stock rises as it works on a hantavirus vaccine after a cruise outbreak, but the disease is rare and vaccines will take years.

Moderna Stock Surges as Hantavirus Vaccine Research Lights Up After Cruise Ship Outbreak
"An illustration of a hantavirus." Credit: Ruslanas Baranauskas/Science Photo Library/National Geographic
Already have an account? Sign in.